| Literature DB >> 11275700 |
C Bousquet1, E Puente, L Buscail, N Vaysse, C Susini.
Abstract
Over the past decade, antiproliferative effects of somatostatin and analogs have been reported in many somatostatin receptor-positive normal and tumor cell types. Regarding the molecular mechanisms involved, somatostatin or analogs mediate their action through both indirect and direct effects. Somatostatin acts through five somatostatin receptors (SSTR1-5) which are variably expressed in normal and tumor cells. These receptors regulate a variety of signal transduction pathways including inhibition of adenylate cyclase, regulation of ion channels, regulation of serine/threonine and tyrosine kinases and phosphatases. This review focuses on recent advances in biological mechanisms involved in the antineoplastic activity of somatostatin and analogs. Copyright 2001 S. Karger AG, BaselEntities:
Mesh:
Substances:
Year: 2001 PMID: 11275700 DOI: 10.1159/000049159
Source DB: PubMed Journal: Chemotherapy ISSN: 0009-3157 Impact factor: 2.544